MedTrace Logo

Clinical Investigation on Lips Treated With HA-filler

NCT07188818 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-03-27

No results posted yet for this study

Summary

A post-market-clinical follow-up investigation to confirm the clinical safety and performance profile of Decoria® Essence for the correction and improvement of lips profile.

Conditions

  • Aesthetic Correction of the Lips

Interventions

DEVICE

Decoria Essence

Decoria® Essence is a hyaluronic acid based, BDDE-crosslinked dermal filler. Decoria® Essence dermal fillers are injected into dermal tissue to improve the volume and the contouring of the lips to desired level of correction by supporting the overlying tissue. Injection volume will be determined by the treating investigator according to the instructions for Use (IFU).

Sponsors & Collaborators

  • Key2Compliance

    collaborator INDUSTRY

  • Bohus Biotech AB

    lead INDUSTRY

Principal Investigators

  • Lucian Grema, M.D. · Diagnostiskt Centrum Hud, Konsult LBG vard AB

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-12-09
Primary Completion
2026-07-31
Completion
2026-07-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07188818 on ClinicalTrials.gov